{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:48:46Z","timestamp":1782211726602,"version":"3.54.5"},"reference-count":198,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zunyi Science and Technology Bureau","award":["Zunyi Science and Technology Talent Team Project [2024] No. 6"],"award-info":[{"award-number":["Zunyi Science and Technology Talent Team Project [2024] No. 6"]}]},{"name":"Zunshi Science and Technology Cooperation Letter","award":["No. 39 (2023)"],"award-info":[{"award-number":["No. 39 (2023)"]}]},{"name":"Science and technology research topic of traditional Chinese medicine and ethnic medicine of Guizhou Provincial Administration of Traditional Chinese Medicine","award":["(QZYY-2024-094)"],"award-info":[{"award-number":["(QZYY-2024-094)"]}]},{"name":"Health Commission of Sichuan Province Medical Science and Technology Program","award":["No: 24QNMP019"],"award-info":[{"award-number":["No: 24QNMP019"]}]},{"name":"Scientific Research Projects of the Sichuan Provincial Administration of Traditional Chinese Medicine","award":["25MSZX259"],"award-info":[{"award-number":["25MSZX259"]}]},{"name":"Sichuan Province Natural Science Foundation","award":["2026NSFSC1634"],"award-info":[{"award-number":["2026NSFSC1634"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04529-5","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:37:42Z","timestamp":1779151062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bibliometric analysis of nanomaterials in the diagnosis and treatment of neurological and psychiatric disorders (1997\u20132025): trends and future directions"],"prefix":"10.1186","volume":"24","author":[{"given":"Min","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-kun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"4529_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s12272-024-01527-9","volume":"48","author":"S Lamichhane","year":"2025","unstructured":"Lamichhane S, Seo JE, Jeong JH, Lee S, Lee S. Ideal animal models according to multifaceted mechanisms and peculiarities in neurological disorders: present and challenges. Arch Pharm Res. 2025;48:62\u201388.","journal-title":"Arch Pharm Res"},{"key":"4529_CR2","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1007\/s10787-025-01831-w","volume":"33","author":"LCP Dharshini","year":"2025","unstructured":"Dharshini LCP, Sakthivel KM, Rex KGR, Rasmi RR. Targeting the redox neuroinflammatory nexus: insights into Alzheimer\u2019s and Parkinson\u2019s diseases. Inflammopharmacology. 2025;33:3885\u201395.","journal-title":"Inflammopharmacology"},{"key":"4529_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pneurobio.2017.07.003","volume":"157","author":"L Huang","year":"2017","unstructured":"Huang L, Hu J, Huang S, Wang B, Siaw-Debrah F, Nyanzu M, et al. Nanomaterial applications for neurological diseases and central nervous system injury. Prog Neurobiol. 2017;157:29\u201348.","journal-title":"Prog Neurobiol"},{"key":"4529_CR4","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.2174\/1381612821666150531164124","volume":"21","author":"R Chhabra","year":"2015","unstructured":"Chhabra R, Tosi G, Grabrucker AM. Emerging use of nanotechnology in the treatment of neurological disorders. Curr Pharm Des. 2015;21:3111\u201330.","journal-title":"Curr Pharm Des"},{"key":"4529_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphyslip.2025.105510","volume":"270","author":"P Tiwary","year":"2025","unstructured":"Tiwary P, Oswal K, Varghese R, Anchan H, Gupta P. Solid lipid nanoparticles in the diagnosis and treatment of prostate cancer: a comprehensive review of two decades of advancements. Chem Phys Lipids. 2025;270:105510.","journal-title":"Chem Phys Lipids"},{"key":"4529_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.colcom.2021.100561","volume":"46","author":"R Varghese","year":"2022","unstructured":"Varghese R, Salvi S, Sood P, Kulkarni B, Kumar D. Cubosomes in cancer drug delivery: a review. Colloid Interface Sci Commun. 2022;46:100561.","journal-title":"Colloid Interface Sci Commun"},{"key":"4529_CR7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1039\/D5PM00109A","volume":"2","author":"P Tiwary","year":"2025","unstructured":"Tiwary P, Oswal K, Varghese R, Peri RV, Gupta P. Solid lipid nanoparticles in cervical cancer: a comprehensive review of a decade of progress and prospects. RSC Pharmaceutics. 2025;2:930\u201349.","journal-title":"RSC Pharmaceutics"},{"key":"4529_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.115122","volume":"257","author":"P Tiwary","year":"2026","unstructured":"Tiwary P, Oswal K, Varghese R, Gupta P. Solid lipid nanoparticles in imaging, diagnostics and theranostics: a review of a decade of innovations and clinical applications. Colloids Surf B Biointerfaces. 2026;257:115122.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4529_CR9","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1007\/s00213-025-06862-3","volume":"242","author":"Y Deng","year":"2025","unstructured":"Deng Y, Feng Y, Ye B, Hu L, Qi L, Wang C, et al. Application of nanomaterials in central nervous system disorders. Psychopharmacology. 2025;242:2619\u201332.","journal-title":"Psychopharmacology"},{"key":"4529_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03415-w","volume":"23","author":"S Liu","year":"2025","unstructured":"Liu S, Jin X, Ge Y, Dong J, Liu X, Pei X, et al. Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood-brain barrier permeability. J Nanobiotechnol. 2025;23:382.","journal-title":"J Nanobiotechnol"},{"key":"4529_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva C, Pra\u00e7a C, Ferreira R, Santos T, Ferreira L, Bernardino L. Nanoparticle-mediated brain drug delivery: overcoming blood\u2013brain barrier to treat neurodegenerative diseases. J Control Release. 2016;235:34\u201347.","journal-title":"J Control Release"},{"key":"4529_CR12","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1038\/am.2013.88","volume":"6","author":"C Xu","year":"2014","unstructured":"Xu C, Qu X. Cerium oxide nanoparticle: a remarkably versatile rare earth nanomaterial for biological applications. NPG Asia Mater. 2014;6:e90\u2013e90.","journal-title":"NPG Asia Mater"},{"key":"4529_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/nnano.2006.91","volume":"1","author":"J Chen","year":"2006","unstructured":"Chen J, Patil S, Seal S, McGinnis JF. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol. 2006;1:142\u201350.","journal-title":"Nat Nanotechnol"},{"key":"4529_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1411104","volume":"16","author":"X Zhang","year":"2024","unstructured":"Zhang X, Yu H, Feng J. Emerging role of microglia in inter-cellular transmission of \u03b1-synuclein in Parkinson\u2019s disease. Front Aging Neurosci. 2024;16:1411104.","journal-title":"Front Aging Neurosci"},{"key":"4529_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-01009-9","volume":"11","author":"M Yal\u00e7in","year":"2025","unstructured":"Yal\u00e7in M, Grande V, Outeiro TF, Rel\u00f3gio A. Circadian clock dysfunction in Parkinson\u2019s disease: mechanisms, consequences, and therapeutic strategy. npj Parkinsons Dis. 2025;11:213.","journal-title":"npj Parkinsons Dis"},{"key":"4529_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2174\/0113892037275221240327042353","volume":"25","author":"K Singh","year":"2024","unstructured":"Singh K, Gupta JK, Kumar S, Soni U. A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of bioactive peptides. Curr Protein Pept Sci. 2024;25:507\u201326.","journal-title":"Curr Protein Pept Sci"},{"key":"4529_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40259-024-00646-5","volume":"38","author":"K Manoutcharian","year":"2024","unstructured":"Manoutcharian K, Gevorkian G. Recombinant antibody fragments for immunotherapy of Parkinson\u2019s disease. BioDrugs. 2024;38:249\u201357.","journal-title":"BioDrugs"},{"key":"4529_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson\u2019s disease. Lancet. 2024;403:293\u2013304.","journal-title":"Lancet"},{"key":"4529_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s12031-023-02128-9","volume":"73","author":"I Smaili","year":"2023","unstructured":"Smaili I, Tibar H, Rahmani M, Machkour N, Razine R, Darai HN, et al. Gene panel sequencing analysis revealed a strong contribution of rare coding variants to the risk of Parkinson\u2019s disease in sporadic Moroccan patients. J Mol Neurosci. 2023;73:391\u2013402.","journal-title":"J Mol Neurosci"},{"key":"4529_CR20","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.21037\/qims-24-14","volume":"14","author":"F Chen","year":"2024","unstructured":"Chen F, Chen L, Cai G, Wang Y, Li Y, Xu H, et al. Association of synuclein alpha (SNCA) gene polymorphisms with spontaneous brain activity in patients with Parkinson\u2019s disease. Quant Imaging Med Surg. 2024;14:6806\u201319.","journal-title":"Quant Imaging Med Surg"},{"key":"4529_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12974-016-0588-5","volume":"13","author":"K Brockmann","year":"2016","unstructured":"Brockmann K, Apel A, Schulte C, Schneiderhan-Marra N, Pont-Sunyer C, Vilas D, et al. Inflammatory profile in LRRK2-associated prodromal and clinical PD. J Neuroinflammation. 2016;13:122.","journal-title":"J Neuroinflammation"},{"key":"4529_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108130","volume":"26","author":"KJ He","year":"2023","unstructured":"He KJ, Zhang JB, Liu JY, Zhao FL, Yao XY, Tang YT, et al. LRRK2 G2019S promotes astrocytic inflammation induced by oligomeric \u03b1-synuclein through NF-\u03baB pathway. iScience. 2023;26:108130.","journal-title":"iScience"},{"key":"4529_CR23","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s40265-019-01104-1","volume":"79","author":"D Savitt","year":"2019","unstructured":"Savitt D, Jankovic J. Targeting \u03b1-synuclein in Parkinson\u2019s disease: progress towards the development of disease-modifying therapeutics. Drugs. 2019;79:797\u2013810.","journal-title":"Drugs"},{"key":"4529_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-023-00363-z","volume":"12","author":"A Drobny","year":"2023","unstructured":"Drobny A, Boros FA, Balta D, Prieto Huarcaya S, Caylioglu D, Qazi N, et al. Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models. Transl Neurodegener. 2023;12:31.","journal-title":"Transl Neurodegener"},{"key":"4529_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10571-020-00849-8","volume":"41","author":"J Sassone","year":"2021","unstructured":"Sassone J, Reale C, Dati G, Regoni M, Pellecchia MT, Garavaglia B. The role of VPS35 in the pathobiology of Parkinson\u2019s disease. Cell Mol Neurobiol. 2021;41:199\u2013227.","journal-title":"Cell Mol Neurobiol"},{"key":"4529_CR26","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1002\/mds.30006","volume":"39","author":"SRL Vieira","year":"2024","unstructured":"Vieira SRL, Mezabrovschi R, Toffoli M, Del Pozo SL, Menozzi E, Mullin S, et al. Consensus guidance for genetic counseling in GBA1 variants: a focus on Parkinson\u2019s disease. Mov Disord. 2024;39:2144\u201354.","journal-title":"Mov Disord"},{"issue":"5","key":"4529_CR27","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/biom13050726","volume":"13","author":"B Xu","year":"2023","unstructured":"Xu B, Fan F, Liu Y, Liu Y, Zhou L, Yu H. Distinct effects of familial Parkinson\u2019s disease-associated mutations on \u03b1-synuclein phase separation and amyloid aggregation. Biomolecules. 2023;13(5):726.","journal-title":"Biomolecules"},{"key":"4529_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat8407","volume":"362","author":"T-I Kam","year":"2018","unstructured":"Kam T-I, Mao X, Park H, Chou S-C, Karuppagounder S, Umanah G, et al. Poly(ADP-ribose) drives pathologic \u03b1-synuclein neurodegeneration in Parkinson\u2019s disease. Science. 2018;362:eaat8407.","journal-title":"Science"},{"key":"4529_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-017-1788-5","volume":"135","author":"P Jiang","year":"2018","unstructured":"Jiang P, Dickson DW. Parkinson\u2019s disease: experimental models and reality. Acta Neuropathol. 2018;135:13\u201332.","journal-title":"Acta Neuropathol"},{"key":"4529_CR30","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"K Luk","year":"2012","unstructured":"Luk K, Kehm V, Zhang B, O\u2019Brien P, Trojanowski J, Lee V. Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice. J Exp Med. 2012;209:975\u201386.","journal-title":"J Exp Med"},{"key":"4529_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087205","volume":"24","author":"M Chen","year":"2023","unstructured":"Chen M, Mor DE. Gut-to-brain \u03b1-synuclein transmission in Parkinson\u2019s disease: evidence for prion-like mechanisms. Int J Mol Sci. 2023;24:7205.","journal-title":"Int J Mol Sci"},{"key":"4529_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/imr.13133","volume":"311","author":"JR Lukens","year":"2022","unstructured":"Lukens JR, Williams JL. An introduction to neuroimmunology. Immunol Rev. 2022;311:5\u20138.","journal-title":"Immunol Rev"},{"key":"4529_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.607392","volume":"8","author":"TK Lin","year":"2020","unstructured":"Lin TK, Lin KJ, Lin KL, Liou CW, Chen SD, Chuang YC, et al. When friendship turns sour: effective communication between mitochondria and intracellular organelles in Parkinson\u2019s disease. Front Cell Dev Biol. 2020;8:607392.","journal-title":"Front Cell Dev Biol"},{"key":"4529_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4103\/1673-5374.317957","volume":"17","author":"JD Panes","year":"2022","unstructured":"Panes JD, Wendt A, Ramirez-Molina O, Castro PA, Fuentealba J. Deciphering the role of PGC-1\u03b1 in neurological disorders: from mitochondrial dysfunction to synaptic failure. Neural Regen Res. 2022;17:237\u201345.","journal-title":"Neural Regen Res"},{"issue":"9","key":"4529_CR35","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.3390\/ijms26094451","volume":"26","author":"M Lucchesi","year":"2025","unstructured":"Lucchesi M, Biso L, Bonaso M, Longoni B, Buchignani B, Battini R, et al. Mitochondrial dysfunction in genetic and non-genetic Parkinson\u2019s disease. Int J Mol Sci. 2025;26(9):4451.","journal-title":"Int J Mol Sci"},{"key":"4529_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2022.129381","volume":"437","author":"D Wang","year":"2022","unstructured":"Wang D, Cao L, Zhou X, Wang G, Ma Y, Hao X, et al. Mitigation of honokiol on fluoride-induced mitochondrial oxidative stress, mitochondrial dysfunction, and cognitive deficits through activating AMPK\/PGC-1\u03b1\/Sirt3. J Hazard Mater. 2022;437:129381.","journal-title":"J Hazard Mater"},{"key":"4529_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/15548627.2019.1603548","volume":"16","author":"F Wauters","year":"2020","unstructured":"Wauters F, Cornelissen T, Imberechts D, Martin S, Koentjoro B, Sue C, et al. LRRK2 mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10. Autophagy. 2020;16:203\u201322.","journal-title":"Autophagy"},{"key":"4529_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12974-022-02574-z","volume":"19","author":"SY Liu","year":"2022","unstructured":"Liu SY, Qiao HW, Song TB, Liu XL, Yao YX, Zhao CS, et al. Brain microglia activation and peripheral adaptive immunity in Parkinson\u2019s disease: a multimodal PET study. J Neuroinflammation. 2022;19:209.","journal-title":"J Neuroinflammation"},{"key":"4529_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.12938\/bmfh.19-002","volume":"38","author":"G Uyar","year":"2019","unstructured":"Uyar G, Yildiran H. A nutritional approach to microbiota in Parkinson\u2019s disease. Biosci Microbiota Food Health. 2019;38:115\u201327.","journal-title":"Biosci Microbiota Food Health"},{"key":"4529_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.145413","volume":"473","author":"H Li","year":"2023","unstructured":"Li H, Zhang X, Miao J, Shi Z, Li Z, Wen M, et al. Dual drug-loaded calabash-like nanomotor as an active therapeutic for enhanced chemo-photothermal therapy of orthotopic glioblastoma. Chem Eng J. 2023;473:145413.","journal-title":"Chem Eng J"},{"key":"4529_CR41","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jconrel.2024.11.069","volume":"377","author":"W Wang","year":"2025","unstructured":"Wang W, Zhao Z, Zhang Z, Wu Z, Zhang Y, Wang K, et al. Delivery of small interfering RNA by hydrogen sulfide-releasing nanomotor for the treatment of Parkinson\u2019s disease. J Control Release. 2025;377:648\u201360.","journal-title":"J Control Release"},{"key":"4529_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202105711","volume":"34","author":"W Ji","year":"2022","unstructured":"Ji W, Li Y, Peng H, Zhao R, Shen J, Wu Y, et al. Self-catalytic small interfering RNA nanocarriers for synergistic treatment of neurodegenerative diseases. Adv Mater. 2022;34:2105711.","journal-title":"Adv Mater"},{"key":"4529_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2021.132210","volume":"429","author":"D Lin","year":"2022","unstructured":"Lin D, Li M, Gao Y, Yin L, Guan Y. Brain-targeted gene delivery of ZnO quantum dots nanoplatform for the treatment of Parkinson disease. Chem Eng J. 2022;429:132210.","journal-title":"Chem Eng J"},{"key":"4529_CR44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-118712","volume":"132","author":"H Tang","year":"2018","unstructured":"Tang H, De Matos Simoes R, Shirasaki R, Dashevsky O, Glassner B, Downey-Kopyscinski SL, et al. CRISPR activation screen for drivers of MM cell proliferation. Blood. 2018;132:3197.","journal-title":"Blood"},{"key":"4529_CR45","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1021\/acsnano.3c05864","volume":"18","author":"W Kong","year":"2024","unstructured":"Kong W, Li X, Guo X, Sun Y, Chai W, Chang Y, et al. Ultrasound-assisted CRISPRi-exosome for epigenetic modification of \u03b1-synuclein gene in a mouse model of Parkinson\u2019s disease. ACS Nano. 2024;18:7837\u201351.","journal-title":"ACS Nano"},{"key":"4529_CR46","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1093\/brain\/awaf030","volume":"148","author":"JA Wiseman","year":"2025","unstructured":"Wiseman JA, Halliday GM, Dieriks BV. Neuronal \u03b1-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophy. Brain. 2025;148:2306\u201319.","journal-title":"Brain"},{"key":"4529_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41531-025-01087-9","volume":"11","author":"B Ranxhi","year":"2025","unstructured":"Ranxhi B, Bangash ZR, Chbihi ZM, Qadri Z, Islam NN, Todi SV, et al. Regulation of polyamine interconversion enzymes affects \u03b1-synuclein levels and toxicity in a Drosophila model of Parkinson\u2019s disease. NPJ Parkinsons Dis. 2025;11:231.","journal-title":"NPJ Parkinsons Dis"},{"key":"4529_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.141606","volume":"461","author":"L Lei","year":"2023","unstructured":"Lei L, Tu Q, Zhang X, Xiang S, Xiao B, Zhai S, et al. Stimulus-responsive curcumin-based polydopamine nanoparticles for targeting Parkinson\u2019s disease by modulating \u03b1-synuclein aggregation and reactive oxygen species. Chem Eng J. 2023;461:141606.","journal-title":"Chem Eng J"},{"key":"4529_CR49","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41418-020-0602-4","volume":"28","author":"H Guo","year":"2021","unstructured":"Guo H, Pu M, Tai Y, Chen Y, Lu H, Qiao J, et al. Nuclear miR-30b-5p suppresses TFEB-mediated lysosomal biogenesis and autophagy. Cell Death Differ. 2021;28:320\u201336.","journal-title":"Cell Death Differ"},{"key":"4529_CR50","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1021\/acsnano.9b06453","volume":"14","author":"J Liu","year":"2020","unstructured":"Liu J, Liu C, Zhang J, Zhang Y, Liu K, Song J-X, et al. A self-assembled \u03b1-synuclein nanoscavenger for Parkinson\u2019s disease. ACS Nano. 2020;14:1533\u201349.","journal-title":"ACS Nano"},{"key":"4529_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202404576","volume":"36","author":"M He","year":"2024","unstructured":"He M, Zhang X, Ran X, Zhang Y, Nie X, Xiao B, et al. Black phosphorus nanosheets protect neurons by degrading aggregative \u03b1-syn and clearing ROS in Parkinson\u2019s disease. Adv Mater. 2024;36:2404576.","journal-title":"Adv Mater"},{"key":"4529_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2021.100972","volume":"82","author":"BN Lizama","year":"2021","unstructured":"Lizama BN, Chu CT. Neuronal autophagy and mitophagy in Parkinson\u2019s disease. Mol Aspects Med. 2021;82:100972.","journal-title":"Mol Aspects Med"},{"key":"4529_CR53","doi-asserted-by":"publisher","first-page":"17979","DOI":"10.1021\/acsnano.3c04308","volume":"17","author":"X Xia","year":"2023","unstructured":"Xia X, Li H, Xu X, Zhao G, Du M. Facilitating pro-survival mitophagy for alleviating Parkinson\u2019s disease via sequence-targeted lycopene nanodots. ACS Nano. 2023;17:17979\u201395.","journal-title":"ACS Nano"},{"key":"4529_CR54","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.1021\/acsnano.2c12614","volume":"17","author":"B Li","year":"2023","unstructured":"Li B, Bai Y, Yion C, Wang H, Su X, Feng G, et al. Single-atom nanocatalytic therapy for suppression of neuroinflammation by inducing autophagy of abnormal mitochondria. ACS Nano. 2023;17:7511\u201329.","journal-title":"ACS Nano"},{"key":"4529_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102438","volume":"58","author":"Y Xu","year":"2024","unstructured":"Xu Y, Yan G, Zhao J, Ren Y, Xiao Q, Tan M, et al. Plant-derived exosomes as cell homogeneous nanoplatforms for brain biomacromolecules delivery ameliorate mitochondrial dysfunction against Parkinson\u2019s disease. Nano Today. 2024;58:102438.","journal-title":"Nano Today"},{"key":"4529_CR56","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/ejn.14290","volume":"49","author":"MG Tansey","year":"2019","unstructured":"Tansey MG, Romero-Ramos M. Immune system responses in Parkinson\u2019s disease: early and dynamic. Eur J Neurosci. 2019;49:364\u201383.","journal-title":"Eur J Neurosci"},{"key":"4529_CR57","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2174\/1381612822666151125000300","volume":"22","author":"Q Alam","year":"2016","unstructured":"Alam Q, Alam MZ, Mushtaq G, Damanhouri GA, Rasool M, Kamal MA, et al. Inflammatory process in Alzheimer\u2019s and Parkinson\u2019s diseases: central role of cytokines. Curr Pharm Des. 2016;22:541\u20138.","journal-title":"Curr Pharm Des"},{"key":"4529_CR58","doi-asserted-by":"crossref","unstructured":"Yadav AK, Verma P, Srivastava A, Srivastava P, Rai RK, Rathour SS, Molecular insights into glial neuroimmune cross reactivity with CNS antigens and its role in neuroinflammation. Inflammopharmacology. 2026","DOI":"10.1007\/s10787-026-02113-9"},{"key":"4529_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103787","volume":"85","author":"T Liu","year":"2025","unstructured":"Liu T, Kong X, Qiao J, Wei J. Decoding Parkinson\u2019s disease: the interplay of cell death pathways, oxidative stress, and therapeutic innovations. Redox Biol. 2025;85:103787.","journal-title":"Redox Biol"},{"key":"4529_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404717","volume":"11","author":"Z Liu","year":"2024","unstructured":"Liu Z, Xiang S, Chen B, Li J, Zhu D, Xu H, et al. Parkinson disease - targeted nanocapsules for synergistic treatment: combining dopamine replacement and neuroinflammation mitigation. Adv Sci (Weinh). 2024;11:e2404717.","journal-title":"Adv Sci (Weinh)"},{"key":"4529_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202303454","volume":"13","author":"Q Li","year":"2024","unstructured":"Li Q, Ding X, Chang Z, Fan X, Pan J, Yang Y, et al. Metal-organic framework based nanozyme system for NLRP3 inflammasome-mediated neuroinflammatory regulation in Parkinson\u2019s disease. Adv Healthc Mater. 2024;13:e2303454.","journal-title":"Adv Healthc Mater"},{"key":"4529_CR62","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.2174\/0929867325666181009161048","volume":"26","author":"N Kustrimovic","year":"2019","unstructured":"Kustrimovic N, Marino F, Cosentino M. Peripheral immunity, immunoaging and neuroinflammation in Parkinson\u2019s disease. Curr Med Chem. 2019;26:3719\u201353.","journal-title":"Curr Med Chem"},{"key":"4529_CR63","doi-asserted-by":"publisher","first-page":"23014","DOI":"10.1021\/acsnano.4c04674","volume":"18","author":"C Zhang","year":"2024","unstructured":"Zhang C, Shao W, Yuan H, Xiao R, Zhang Y, Wei C, et al. Engineered extracellular vesicle-based nanoformulations that coordinate neuroinflammation and immune homeostasis, enhancing Parkinson\u2019s disease therapy. ACS Nano. 2024;18:23014\u201331.","journal-title":"ACS Nano"},{"key":"4529_CR64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41531-022-00296-w","volume":"8","author":"S Rahimpour","year":"2022","unstructured":"Rahimpour S, Zhang SC, Vitek JL, Mitchell KT, Turner DA. Comparative efficacy of surgical approaches to disease modification in Parkinson disease. npj Parkinsons Dis. 2022;8:33.","journal-title":"npj Parkinsons Dis"},{"key":"4529_CR65","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.gene.2016.08.026","volume":"593","author":"Y Wang","year":"2016","unstructured":"Wang Y, Jiaqi C, Zhaoying C, Huimin C. MicroRNA-506-3p regulates neural stem cell proliferation and differentiation through targeting TCF3. Gene. 2016;593:193\u2013200.","journal-title":"Gene"},{"key":"4529_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202406797","volume":"34","author":"S Zhang","year":"2024","unstructured":"Zhang S, Liu Q, Zhou W, Zhao T, Shi J, Ren N, et al. Nano-enabled intracellular bursting of calcium and retinoic acid regulates dopaminergic neuronal differentiation of NSCs for Parkinson\u2019s disease therapy. Adv Funct Mater. 2024;34:2406797.","journal-title":"Adv Funct Mater"},{"key":"4529_CR67","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","volume":"163","author":"S Muralidar","year":"2020","unstructured":"Muralidar S, Ambi SV, Sekaran S, Thirumalai D, Palaniappan B. Role of tau protein in Alzheimer\u2019s disease: the prime pathological player. Int J Biol Macromol. 2020;163:1599\u2013617.","journal-title":"Int J Biol Macromol"},{"key":"4529_CR68","doi-asserted-by":"crossref","unstructured":"Soncu B\u00fcy\u00fcki\u015fcan E, Neuropsychology of Alzheimer\u2019s disease: From preclinical phase to dementia. Appl Neuropsychol Adult. 2025:1\u20139","DOI":"10.1080\/23279095.2025.2469236"},{"key":"4529_CR69","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Wang X. Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell. 2025;16:83\u2013120.","journal-title":"Protein Cell"},{"key":"4529_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-28846-z","volume":"13","author":"I Ulku","year":"2023","unstructured":"Ulku I, Liebsch F, Akerman SC, Schulz JF, Kulic L, Hock C, et al. Mechanisms of amyloid-\u03b234 generation indicate a pivotal role for BACE1 in amyloid homeostasis. Sci Rep. 2023;13:2216.","journal-title":"Sci Rep"},{"issue":"5","key":"4529_CR71","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.3390\/ijms25052727","volume":"25","author":"M Tolar","year":"2024","unstructured":"Tolar M, Hey JA, Power A, Abushakra S. The single toxin origin of Alzheimer\u2019s disease and other neurodegenerative disorders enables targeted approach to treatment and prevention. Int J Mol Sci. 2024;25(5):2727.","journal-title":"Int J Mol Sci"},{"key":"4529_CR72","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","volume":"133","author":"T Guo","year":"2017","unstructured":"Guo T, Noble W, Hanger DP. Roles of tau protein in health and disease. Acta Neuropathol. 2017;133:665\u2013704.","journal-title":"Acta Neuropathol"},{"key":"4529_CR73","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.2174\/1381612825666191011102444","volume":"25","author":"MT Kabir","year":"2019","unstructured":"Kabir MT, Sufian MA, Uddin MS, Begum MM, Akhter S, Islam A, et al. NMDA receptor antagonists: repositioning of Memantine as a multitargeting agent for Alzheimer\u2019s therapy. Curr Pharm Des. 2019;25:3506\u201318.","journal-title":"Curr Pharm Des"},{"key":"4529_CR74","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12951-022-01332-w","volume":"20","author":"X Xian","year":"2022","unstructured":"Xian X, Cai LL, Li Y, Wang RC, Xu YH, Chen YJ, et al. Neuron secrete exosomes containing miR-9-5p to promote polarization of M1 microglia in depression. J Nanobiotechnology. 2022;20:122.","journal-title":"J Nanobiotechnology"},{"key":"4529_CR75","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1161\/ATVBAHA.122.318058","volume":"42","author":"RP Brandes","year":"2022","unstructured":"Brandes RP, Wittig I. Calcium-controlled reactive oxygen species afterburner perpetuates endothelial damage after radiation therapy. Arterioscler Thromb Vasc Biol. 2022;42:1137\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4529_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, et al. Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Transl Med. 2011;3:89ra57.","journal-title":"Sci Transl Med"},{"key":"4529_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413633","author":"L Benussi","year":"2021","unstructured":"Benussi L, Longobardi A, Kocoglu C, Carrara M, Bellini S, Ferrari C, et al. Investigating the endo-lysosomal system in major neurocognitive disorders due to Alzheimer\u2019s disease, frontotemporal lobar degeneration and lewy body disease: evidence for SORL1 as a cross-disease gene. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222413633.","journal-title":"Int J Mol Sci"},{"key":"4529_CR78","doi-asserted-by":"publisher","first-page":"7397","DOI":"10.1007\/s00018-021-03986-5","volume":"78","author":"Y Li","year":"2021","unstructured":"Li Y, Laws SM, Miles LA, Wiley JS, Huang X, Masters CL, et al. Genomics of Alzheimer\u2019s disease implicates the innate and adaptive immune systems. Cell Mol Life Sci. 2021;78:7397\u2013426.","journal-title":"Cell Mol Life Sci"},{"key":"4529_CR79","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.sajb.2025.03.014","volume":"180","author":"N Teerapattarakan","year":"2025","unstructured":"Teerapattarakan N, Kamsrijai U, Janyou A, Hankittichai P, Anukanon S, Hawiset T, et al. Preclinical neuropharmacological effects of Centella asiatica-derived asiaticoside and madecassoside in Alzheimer\u2019s disease. S Afr J Bot. 2025;180:171\u201384.","journal-title":"S Afr J Bot"},{"key":"4529_CR80","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S1474-4422(07)70298-3","volume":"7","author":"R Mayeux","year":"2008","unstructured":"Mayeux R, Hyslop PS. Alzheimer\u2019s disease: advances in trafficking. Lancet Neurol. 2008;7:2\u20133.","journal-title":"Lancet Neurol"},{"key":"4529_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201901844","volume":"6","author":"H Yang","year":"2019","unstructured":"Yang H, Li X, Zhu L, Wu X, Zhang S, Huang F, et al. Heat shock protein inspired nanochaperones restore Amyloid-\u03b2 homeostasis for preventative therapy of Alzheimer\u2019s disease. Adv Sci (Weinh). 2019;6:1901844.","journal-title":"Adv Sci (Weinh)"},{"key":"4529_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.101756","volume":"48","author":"Q Feng","year":"2023","unstructured":"Feng Q, Wang N, Zhang X, Mei Y, Fu R, Chen J, et al. Nanoparticle cluster depolymerizes and removes amyloid fibrils for Alzheimer\u2019s disease treatment. Nano Today. 2023;48:101756.","journal-title":"Nano Today"},{"key":"4529_CR83","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1021\/acsanm.3c06162","volume":"7","author":"J Tian","year":"2024","unstructured":"Tian J, Gao N, Wang M, Zhou M, Ling G, Zhang P. Application of magnetic micro\/nanomotors in biomedicine. ACS Appl Nano Mater. 2024;7:5745\u201360.","journal-title":"ACS Appl Nano Mater"},{"key":"4529_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202407154","volume":"20","author":"X Lin","year":"2024","unstructured":"Lin X, Dong X, Sun Y. Dual-carbon dots composite: a multifunctional photo-propelled nanomotor against Alzheimer\u2019s \u03b2-Amyloid. Small. 2024;20:e2407154.","journal-title":"Small"},{"key":"4529_CR85","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3233\/JAD-215699","volume":"87","author":"CK Kim","year":"2022","unstructured":"Kim CK, Lee YR, Ong L, Gold M, Kalali A, Sarkar J. Alzheimer\u2019s disease: key insights from two decades of clinical trial failures. J Alzheimers Dis. 2022;87:83\u2013100.","journal-title":"J Alzheimers Dis"},{"key":"4529_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.884705","volume":"9","author":"M Alipour","year":"2022","unstructured":"Alipour M, Motavaf M, Abdolmaleki P, Zali A, Ashrafi F, Safari S, et al. Structural analysis and conformational dynamics of short helical hyperphosphorylated segments of Tau protein (sequence 254\u2013290) in Alzheimer\u2019s disease: a molecular dynamics simulation study. Front Mol Biosci. 2022;9:884705.","journal-title":"Front Mol Biosci"},{"key":"4529_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00499","volume":"22","author":"CA Sandhof","year":"2025","unstructured":"Sandhof CA, Murray HFB, Silva MC, Haggarty SJ. Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer\u2019s disease & beyond. Neurotherapeutics. 2025;22:e00499.","journal-title":"Neurotherapeutics"},{"key":"4529_CR88","volume":"11","author":"H Wang","year":"2024","unstructured":"Wang H, Yu SY, Nielsen S, Wang X, Zhao WW. Mitochondrial complex I: the key to sustained microglia activation and neuroinflammation maintenance. Mil Med Res. 2024;11:47.","journal-title":"Mil Med Res"},{"key":"4529_CR89","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.7150\/thno.98462","volume":"14","author":"Y Gu","year":"2024","unstructured":"Gu Y, Zhang Q, Huang H, Ho KHW, Zhang Y, Yi C, et al. Tau-targeting multifunctional nanocomposite based on tannic acid-metal for near-infrared fluorescence\/magnetic resonance bimodal imaging-guided combinational therapy in Alzheimer\u2019s disease. Theranostics. 2024;14:6218\u201335.","journal-title":"Theranostics"},{"key":"4529_CR90","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3233\/JAD-140933","volume":"43","author":"P Kumar","year":"2015","unstructured":"Kumar P, Jha NK, Jha SK, Ramani K, Ambasta RK. Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer\u2019s disease. J Alzheimers Dis. 2015;43:341\u201361.","journal-title":"J Alzheimers Dis"},{"issue":"14","key":"4529_CR91","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.3390\/cells11142250","volume":"11","author":"YT Wang","year":"2022","unstructured":"Wang YT, Lu JH. Chaperone-mediated autophagy in neurodegenerative diseases: molecular mechanisms and pharmacological opportunities. Cells. 2022;11(14):2250.","journal-title":"Cells"},{"key":"4529_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202313869","volume":"36","author":"L Xu","year":"2024","unstructured":"Xu L, Wu X, Zhao S, Hu H, Wang S, Zhang Y, et al. Harnessing nanochaperone-mediated autophagy for selective clearance of pathogenic Tau protein in Alzheimer\u2019s disease. Adv Mater. 2024;36:e2313869.","journal-title":"Adv Mater"},{"issue":"1","key":"4529_CR93","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/biomedicines9010005","volume":"9","author":"MA Rahman","year":"2020","unstructured":"Rahman MA, Rahman MS, Rahman MDH, Rasheduzzaman M, Mamun-Or-Rashid A, Uddin MJ, et al. Modulatory effects of autophagy on APP processing as a potential treatment target for Alzheimer\u2019s disease. Biomedicines. 2020;9(1):5.","journal-title":"Biomedicines"},{"key":"4529_CR94","doi-asserted-by":"publisher","first-page":"5263","DOI":"10.1021\/acsnano.0c10690","volume":"15","author":"H Sun","year":"2021","unstructured":"Sun H, Zhong Y, Zhu X, Liao H, Lee J, Chen Y, et al. A tauopathy-homing and autophagy-activating nanoassembly for specific clearance of pathogenic Tau in Alzheimer\u2019s disease. ACS Nano. 2021;15:5263\u201375.","journal-title":"ACS Nano"},{"key":"4529_CR95","doi-asserted-by":"publisher","first-page":"711","DOI":"10.4155\/fmc-2017-0073","volume":"9","author":"S Gunesch","year":"2017","unstructured":"Gunesch S, Schramm S, Decker M. Natural antioxidants in hybrids for the treatment of neurodegenerative diseases: a successful strategy? Future Med Chem. 2017;9:711\u20133.","journal-title":"Future Med Chem"},{"key":"4529_CR96","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.biomaterials.2019.01.037","volume":"197","author":"L Zhang","year":"2019","unstructured":"Zhang L, Zhao P, Yue C, Jin Z, Liu Q, Du X, et al. Sustained release of bioactive hydrogen by Pd hydride nanoparticles overcomes Alzheimer\u2019s disease. Biomaterials. 2019;197:393\u2013404.","journal-title":"Biomaterials"},{"key":"4529_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-020-00189-z","volume":"9","author":"L Wang","year":"2020","unstructured":"Wang L, Yin YL, Liu XZ, Shen P, Zheng YG, Lan XR, et al. Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease. Transl Neurodegener. 2020;9:10.","journal-title":"Transl Neurodegener"},{"key":"4529_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2023.142679","volume":"464","author":"X Yuan","year":"2023","unstructured":"Yuan X, Tang R, Jia Z, Chen Y, Liu J, Liu Y. Zn2+-responsive palladium nanoclusters synergistically manage Alzheimer\u2019s disease through neuroprotection and inhibition of oxidative stress. Chem Eng J. 2023;464:142679.","journal-title":"Chem Eng J"},{"key":"4529_CR99","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1039\/D3BM01900D","volume":"12","author":"V Sarnatskaya","year":"2024","unstructured":"Sarnatskaya V, Shlapa Y, Kolesnik D, Lykhova O, Klymchuk D, Solopan S, et al. Bioactivity of cerium dioxide nanoparticles as a function of size and surface features. Biomater Sci. 2024;12:2689\u2013704.","journal-title":"Biomater Sci"},{"key":"4529_CR100","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1021\/acsami.1c17861","volume":"14","author":"K Ge","year":"2022","unstructured":"Ge K, Mu Y, Liu M, Bai Z, Liu Z, Geng D, et al. Gold nanorods with spatial separation of CeO(2) deposition for plasmonic-enhanced antioxidant stress and photothermal therapy of Alzheimer\u2019s disease. ACS Appl Mater Interfaces. 2022;14:3662\u201374.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4529_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68144-6","volume":"10","author":"S Dash","year":"2020","unstructured":"Dash S, Balasubramaniam M, Mart\u00ednez-Rivera FJ, Godino A, Peck EG, Patnaik S, et al. Cocaine-regulated microrna miR-124 controls poly (ADP-ribose) polymerase-1 expression in neuronal cells. Sci Rep. 2020;10:11197.","journal-title":"Sci Rep"},{"key":"4529_CR102","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202107534","volume":"18","author":"Q Ouyang","year":"2022","unstructured":"Ouyang Q, Liu K, Zhu Q, Deng H, Le Y, Ouyang W, et al. Brain-penetration and neuron-targeting DNA nanoflowers co-delivering miR-124 and Rutin for synergistic therapy of Alzheimer\u2019s disease. Small. 2022;18:e2107534.","journal-title":"Small"},{"key":"4529_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-023-00343-3","volume":"12","author":"C de Dios","year":"2023","unstructured":"de Dios C, Abadin X, Roca-Agujetas V, Jimenez-Martinez M, Morales A, Trullas R, et al. Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis. Transl Neurodegener. 2023;12:10.","journal-title":"Transl Neurodegener"},{"key":"4529_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301361","volume":"10","author":"Y Su","year":"2023","unstructured":"Su Y, Huang Y, Kou Q, Lu L, Jiang H, Li X, et al. Study on the role of an erythrocyte membrane-coated nanotheranostic system in targeted immune regulation of Alzheimer\u2019s disease. Adv Sci (Weinh). 2023;10:e2301361.","journal-title":"Adv Sci (Weinh)"},{"key":"4529_CR105","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1021\/acsnano.3c13150","volume":"18","author":"S Jiang","year":"2024","unstructured":"Jiang S, Cai G, Yang Z, Shi H, Zeng H, Ye Q, et al. Biomimetic nanovesicles as a dual gene delivery system for the synergistic gene therapy of Alzheimer\u2019s disease. ACS Nano. 2024;18:11753\u201368.","journal-title":"ACS Nano"},{"key":"4529_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097739","author":"Q Cheng","year":"2023","unstructured":"Cheng Q, Ma X, Liu J, Feng X, Liu Y, Wang Y, et al. Pharmacological inhibition of the asparaginyl endopeptidase (AEP) in an Alzheimer\u2019s disease model improves the survival and efficacy of transplanted neural stem cells. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24097739.","journal-title":"Int J Mol Sci"},{"key":"4529_CR107","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202006357","volume":"33","author":"D Huang","year":"2021","unstructured":"Huang D, Cao Y, Yang X, Liu Y, Zhang Y, Li C, et al. A nanoformulation-mediated multifunctional stem cell therapy with improved Beta-Amyloid clearance and neural regeneration for Alzheimer\u2019s disease. Adv Mater. 2021;33:e2006357.","journal-title":"Adv Mater"},{"key":"4529_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25074073","author":"DA D\u00edaz-Pi\u00f1a","year":"2024","unstructured":"D\u00edaz-Pi\u00f1a DA, Rivera-Ram\u00edrez N, Garc\u00eda-L\u00f3pez G, D\u00edaz NF, Molina-Hern\u00e1ndez A. Calcium and neural stem cell proliferation. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25074073.","journal-title":"Int J Mol Sci"},{"key":"4529_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00478","volume":"12","author":"JP Pan","year":"2018","unstructured":"Pan JP, Hu Y, Wang JH, Xin YR, Jiang JX, Chen KQ, et al. Methyl 3,4-Dihydroxybenzoate induces neural stem cells to differentiate into cholinergic neurons in vitro. Front Cell Neurosci. 2018;12:478.","journal-title":"Front Cell Neurosci"},{"key":"4529_CR110","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.omtn.2019.07.009","volume":"17","author":"FK Ekman","year":"2019","unstructured":"Ekman FK, Ojala DS, Adil MM, Lopez PA, Schaffer DV, Gaj T. CRISPR-Cas9-mediated genome editing increases lifespan and improves motor deficits in a Huntington\u2019s disease mouse model. Mol Ther Nucleic Acids. 2019;17:829\u201339.","journal-title":"Mol Ther Nucleic Acids"},{"key":"4529_CR111","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000481172","volume":"17","author":"ARS Ramos","year":"2017","unstructured":"Ramos ARS, Garrett C. Huntington\u2019s disease: premotor phase. Neurodegener Dis. 2017;17:313\u201322.","journal-title":"Neurodegener Dis"},{"issue":"21","key":"4529_CR112","doi-asserted-by":"publisher","first-page":"11787","DOI":"10.3390\/ijms252111787","volume":"25","author":"X Li","year":"2024","unstructured":"Li X, Tong H, Xu S, Zhou G, Yang T, Yin S, et al. Neuroinflammatory proteins in Huntington\u2019s disease: insights into mechanisms, diagnosis, and therapeutic implications. Int J Mol Sci. 2024;25(21):11787.","journal-title":"Int J Mol Sci"},{"key":"4529_CR113","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s13311-019-00782-9","volume":"16","author":"J Creus-Muncunill","year":"2019","unstructured":"Creus-Muncunill J, Ehrlich ME. Cell-autonomous and non-cell-autonomous pathogenic mechanisms in Huntington\u2019s disease: insights from in vitro and in vivo models. Neurotherapeutics. 2019;16:957\u201378.","journal-title":"Neurotherapeutics"},{"key":"4529_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.769184","volume":"8","author":"OD Jarosi\u0144ska","year":"2021","unstructured":"Jarosi\u0144ska OD, R\u00fcdiger SGD. Molecular strategies to target protein aggregation in Huntington\u2019s disease. Front Mol Biosci. 2021;8:769184.","journal-title":"Front Mol Biosci"},{"key":"4529_CR115","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/bpa.12426","volume":"26","author":"U R\u00fcb","year":"2016","unstructured":"R\u00fcb U, Seidel K, Heinsen H, Vonsattel JP, den Dunnen WF, Korf HW. Huntington\u2019s disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain. Brain Pathol. 2016;26:726\u201340.","journal-title":"Brain Pathol"},{"key":"4529_CR116","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2024.09.015","volume":"113","author":"JE Palmer","year":"2025","unstructured":"Palmer JE, Wilson N, Son SM, Obrocki P, Wrobel L, Rob M, et al. Autophagy, aging, and age-related neurodegeneration. Neuron. 2025;113:29\u201348.","journal-title":"Neuron"},{"issue":"6513","key":"4529_CR117","doi-asserted-by":"publisher","first-page":"eaay3302","DOI":"10.1126\/science.aay3302","volume":"370","author":"J Yan","year":"2020","unstructured":"Yan J, Bengtson CP, Buchthal B, Hagenston AM, Bading H. Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants. Science. 2020;370(6513):eaay3302.","journal-title":"Science"},{"key":"4529_CR118","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jconrel.2022.09.040","volume":"351","author":"JW Lee","year":"2022","unstructured":"Lee JW, Choi J, Choi Y, Kim K, Yang Y, Kim SH, et al. Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy. J Control Release. 2022;351:713\u201326.","journal-title":"J Control Release"},{"key":"4529_CR119","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1021\/acsanm.2c03936","volume":"6","author":"SS Rohiwal","year":"2023","unstructured":"Rohiwal SS, Nguyen TD, Kamenna E, Klima J, Vaskovicova M, Sekac D, et al. Iron oxide nanoparticle-mediated siRNA delivery system for Huntington\u2019s disease treatment. ACS Applied Nano Materials. 2023;6:5106\u201316.","journal-title":"ACS Applied Nano Materials"},{"key":"4529_CR120","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.1093\/nar\/gkz500","volume":"47","author":"XH Liang","year":"2019","unstructured":"Liang XH, Nichols JG, Hsu CW, Vickers TA, Crooke ST. mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway. Nucleic Acids Res. 2019;47:6900\u201316.","journal-title":"Nucleic Acids Res"},{"key":"4529_CR121","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jconrel.2024.01.011","volume":"367","author":"NS Caron","year":"2024","unstructured":"Caron NS, Aly AE, Findlay Black H, Martin DDO, Schmidt ME, Ko S, et al. Systemic delivery of mutant huntingtin lowering antisense oligonucleotides to the brain using apolipoprotein A-I nanodisks for Huntington disease. J Control Release. 2024;367:27\u201344.","journal-title":"J Control Release"},{"key":"4529_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2025.e00557","volume":"22","author":"CY Cheng","year":"2025","unstructured":"Cheng CY, Chen KP, Tseng TS, Hua KF, Ju TC. The therapeutic potential of (R)-carvedilol in Huntington\u2019s disease through enhancement of autophagy-lysosomal pathway via GSK-3\u03b2 inhibition. Neurotherapeutics. 2025;22:e00557.","journal-title":"Neurotherapeutics"},{"key":"4529_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119248","volume":"216","author":"L Zhang","year":"2019","unstructured":"Zhang L, Wei PF, Song YH, Dong L, Wu YD, Hao ZY, et al. MnFe(2)O(4) nanoparticles accelerate the clearance of mutant huntingtin selectively through ubiquitin-proteasome system. Biomaterials. 2019;216:119248.","journal-title":"Biomaterials"},{"key":"4529_CR124","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/10717544.2021.1879315","volume":"28","author":"H Ma","year":"2021","unstructured":"Ma H, Jiang Z, Xu J, Liu J, Guo ZN. Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke. Drug Deliv. 2021;28:357\u201371.","journal-title":"Drug Deliv"},{"key":"4529_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2023.109149","volume":"35","author":"C Xie","year":"2024","unstructured":"Xie C, Liao J, Zhang N, Sun Y, Li Y, Xiong L, et al. Advanced nano drug delivery systems for neuroprotection against ischemic stroke. Chin Chem Lett. 2024;35:109149.","journal-title":"Chin Chem Lett"},{"key":"4529_CR126","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.yexcr.2016.12.028","volume":"351","author":"B Chen","year":"2017","unstructured":"Chen B, Wang G, Li W, Liu W, Lin R, Tao J, et al. Memantine attenuates cell apoptosis by suppressing the calpain-caspase-3 pathway in an experimental model of ischemic stroke. Exp Cell Res. 2017;351:163\u201372.","journal-title":"Exp Cell Res"},{"key":"4529_CR127","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3389\/fncel.2019.00537","volume":"13","author":"Z Ma","year":"2019","unstructured":"Ma Z, Zhang Z, Bai F, Jiang T, Yan C, Wang Q. Electroacupuncture pretreatment alleviates cerebral ischemic injury through \u03b17 Nicotinic Acetylcholine Receptor-mediated phenotypic conversion of microglia. Front Cell Neurosci. 2019;13:537.","journal-title":"Front Cell Neurosci"},{"key":"4529_CR128","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1007\/s00210-023-02804-y","volume":"397","author":"P Bindal","year":"2024","unstructured":"Bindal P, Kumar V, Kapil L, Singh C, Singh A. Therapeutic management of ischemic stroke. Naunyn Schmiedebergs Arch Pharmacol. 2024;397:2651\u201379.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4529_CR129","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202200416","volume":"11","author":"X Quan","year":"2022","unstructured":"Quan X, Han Y, Lu P, Ding Y, Wang Q, Li Y, et al. Annexin V-modified platelet-biomimetic nanomedicine for targeted therapy of acute ischemic stroke. Adv Healthc Mater. 2022;11:e2200416.","journal-title":"Adv Healthc Mater"},{"key":"4529_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202210144","volume":"36","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhao Y, Hou Y, Tang G, Zhang R, Yang Y, et al. A thrombin-activated peptide-templated nanozyme for remedying ischemic stroke via thrombolytic and neuroprotective actions. Adv Mater. 2024;36:e2210144.","journal-title":"Adv Mater"},{"key":"4529_CR131","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41467-023-35895-5","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhao Z, Sun S, Zhang S, Wang Y, Zhang X, et al. Molecularly self-fueled nano-penetrator for nonpharmaceutical treatment of thrombosis and ischemic stroke. Nat Commun. 2023;14:255.","journal-title":"Nat Commun"},{"key":"4529_CR132","doi-asserted-by":"publisher","first-page":"20177","DOI":"10.1039\/D4SC05977H","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang J, Liu Y, Zhao Y, Zhang S, Xu F, Li F. Synergetic effect of mild hypothermia and antioxidant treatment on ROS-mediated neuron injury under oxygen-glucose deprivation investigated by scanning electrochemical microscopy. Chem Sci. 2024;15:20177\u201388.","journal-title":"Chem Sci"},{"key":"4529_CR133","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.1021\/acsnano.8b01994","volume":"12","author":"Q Bao","year":"2018","unstructured":"Bao Q, Hu P, Xu Y, Cheng T, Wei C, Pan L, et al. Simultaneous blood-brain barrier crossing and protection for stroke treatment based on Edaravone-loaded Ceria nanoparticles. ACS Nano. 2018;12:6794\u2013805.","journal-title":"ACS Nano"},{"key":"4529_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2021.133671","volume":"433","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang F, Long L, Li J, Liu Z, Hu C, et al. Dual-function hydrogels with sequential release of GSK3\u03b2 inhibitor and VEGF inhibit inflammation and promote angiogenesis after stroke. Chem Eng J. 2022;433:133671.","journal-title":"Chem Eng J"},{"key":"4529_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43070-z","volume":"14","author":"D Wu","year":"2023","unstructured":"Wu D, Zhou J, Zheng Y, Zheng Y, Zhang Q, Zhou Z, et al. Pathogenesis-adaptive polydopamine nanosystem for sequential therapy of ischemic stroke. Nat Commun. 2023;14:7147.","journal-title":"Nat Commun"},{"key":"4529_CR136","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.tins.2020.04.006","volume":"43","author":"QA Nguyen","year":"2020","unstructured":"Nguyen QA, Moolchand P, Soltesz I. Connecting pathological cellular mechanisms to large-scale seizure structures. Trends Neurosci. 2020;43:547\u20139.","journal-title":"Trends Neurosci"},{"key":"4529_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1552145","volume":"19","author":"A Chai","year":"2025","unstructured":"Chai A. Pleiotropic neurotransmitters: neurotransmitter-receptor crosstalk regulates excitation-inhibition balance in social brain functions and pathologies. Front Neurosci. 2025;19:1552145.","journal-title":"Front Neurosci"},{"key":"4529_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2024.104246","volume":"101","author":"Y Tan","year":"2024","unstructured":"Tan Y, Hashimoto K. Therapeutic potential of ketamine in management of epilepsy: clinical implications and mechanistic insights. Asian J Psychiatr. 2024;101:104246.","journal-title":"Asian J Psychiatr"},{"key":"4529_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106102","volume":"180","author":"E Dossi","year":"2023","unstructured":"Dossi E, Huberfeld G. GABAergic circuits drive focal seizures. Neurobiol Dis. 2023;180:106102.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"4529_CR140","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/cells14020094","volume":"14","author":"F Onat","year":"2025","unstructured":"Onat F, Andersson M, \u00c7ar\u00e7ak N. The role of glial cells in the pathophysiology of epilepsy. Cells. 2025;14(2):94.","journal-title":"Cells"},{"key":"4529_CR141","doi-asserted-by":"publisher","first-page":"16853","DOI":"10.1021\/acsnano.4c02546","volume":"18","author":"Q Ren","year":"2024","unstructured":"Ren Q, Wu H, Zhang Y, Dai J, Chang Z, Nie J, et al. Nongenetic precise neuromodulation and spatiotemporal neuroprotection for epilepsy therapy via rationally designed multifunctional nanotransducer. ACS Nano. 2024;18:16853\u201366.","journal-title":"ACS Nano"},{"key":"4529_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1376762","volume":"17","author":"D Tsuboi","year":"2024","unstructured":"Tsuboi D, Nagai T, Yoshimoto J, Kaibuchi K. Neuromodulator regulation and emotions: insights from the crosstalk of cell signaling. Front Mol Neurosci. 2024;17:1376762.","journal-title":"Front Mol Neurosci"},{"key":"4529_CR143","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202412633","volume":"35","author":"Y Sun","year":"2025","unstructured":"Sun Y, Zhao X, Yang R, Xiao M, Liu W. \u03b1-Lipoic Acid-based nanozyme for treating acute epilepsy. Adv Funct Mater. 2025;35:2412633.","journal-title":"Adv Funct Mater"},{"key":"4529_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2014.00315","volume":"8","author":"G Singhal","year":"2014","unstructured":"Singhal G, Jaehne EJ, Corrigan F, Toben C, Baune BT. Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci. 2014;8:315.","journal-title":"Front Neurosci"},{"key":"4529_CR145","doi-asserted-by":"publisher","first-page":"6652","DOI":"10.7150\/thno.99260","volume":"14","author":"C Geng","year":"2024","unstructured":"Geng C, Ren X, Cao P, Chu X, Wei P, Liu Q, et al. Macrophage membrane\u2012biomimetic nanoparticles target inflammatory microenvironment for epilepsy treatment. Theranostics. 2024;14:6652\u201370.","journal-title":"Theranostics"},{"key":"4529_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2025.102652","volume":"61","author":"R Yang","year":"2025","unstructured":"Yang R, Sun Y, Zhao X, Liu W. pH-responsive dissociable liposome\/ferritin nanoparticles for treating acute epilepsy through regulating microvascular stabilization and remodeling inflammatory microenvironment. Nano Today. 2025;61:102652.","journal-title":"Nano Today"},{"key":"4529_CR147","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12951-025-03408-9","volume":"23","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Chen F, Chen C, Yang Y, Wang L, Zhu J, et al. Coordination acid-engineered Prussian Blue affects glycometabolic reprogramming in microglia for epileptic treatment. J Nanobiotechnol. 2025;23:436.","journal-title":"J Nanobiotechnol"},{"key":"4529_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2025.115630","volume":"490","author":"AG Bertollo","year":"2025","unstructured":"Bertollo AG, Capitanio MZ, Schuh LA, Pradella N, Ign\u00e1cio ZM. Habits and vulnerability or resilience to stress - impact on depressive disorders. Behav Brain Res. 2025;490:115630.","journal-title":"Behav Brain Res"},{"key":"4529_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01738-y","volume":"9","author":"L Cui","year":"2024","unstructured":"Cui L, Li S, Wang S, Wu X, Liu Y, Yu W, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. 2024;9:30.","journal-title":"Signal Transduct Target Ther"},{"key":"4529_CR150","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2174\/1570159X18666201015155816","volume":"19","author":"S Bhatt","year":"2021","unstructured":"Bhatt S, Devadoss T, Manjula SN, Rajangam J. 5-HT(3) receptor antagonism a potential therapeutic approach for the treatment of depression and other disorders. Curr Neuropharmacol. 2021;19:1545\u201359.","journal-title":"Curr Neuropharmacol"},{"issue":"8","key":"4529_CR151","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.3390\/molecules26082149","volume":"26","author":"HR Arias","year":"2021","unstructured":"Arias HR, Targowska-Duda KM, Garc\u00eda-Colunga J, Ortells MO. Is the antidepressant activity of selective serotonin reuptake inhibitors mediated by nicotinic acetylcholine receptors? Molecules. 2021;26(8):2149.","journal-title":"Molecules"},{"key":"4529_CR152","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/S1734-1140(13)71527-5","volume":"65","author":"A G\u0105dek-Michalska","year":"2013","unstructured":"G\u0105dek-Michalska A, Tadeusz J, Rachwalska P, Bugajski J. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems. Pharmacol Rep. 2013;65:1655\u201362.","journal-title":"Pharmacol Rep"},{"key":"4529_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2021.114317","volume":"307","author":"ML Garc\u00eda-Garc\u00eda","year":"2022","unstructured":"Garc\u00eda-Garc\u00eda ML, Tovilla-Z\u00e1rate CA, Villar-Soto M, Ju\u00e1rez-Rojop IE, Gonz\u00e1lez-Castro TB, Genis-Mendoza AD, et al. Fluoxetine modulates the pro-inflammatory process of IL-6, IL-1\u03b2 and TNF-\u03b1 levels in individuals with depression: a systematic review and meta-analysis. Psychiatry Res. 2022;307:114317.","journal-title":"Psychiatry Res"},{"key":"4529_CR154","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1504555","volume":"18","author":"M Puentes-Orozco","year":"2024","unstructured":"Puentes-Orozco M, Albarracin SL, Vel\u00e1squez MM. Neuroinflammation and major depressive disorder: astrocytes at the crossroads. Front Cell Neurosci. 2024;18:1504555.","journal-title":"Front Cell Neurosci"},{"key":"4529_CR155","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1590\/1516-4446-2019-0620","volume":"42","author":"AR Brunoni","year":"2020","unstructured":"Brunoni AR, Carracedo A, Amigo OM, Pellicer AL, Talib L, Carvalho AF, et al. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial. Braz J Psychiatry. 2020;42:128\u201335.","journal-title":"Braz J Psychiatry"},{"key":"4529_CR156","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.biopsych.2014.11.007","volume":"77","author":"BA Samuels","year":"2015","unstructured":"Samuels BA, Leonardo ED, Hen R. Hippocampal subfields and major depressive disorder. Biol Psychiatry. 2015;77:210\u20131.","journal-title":"Biol Psychiatry"},{"key":"4529_CR157","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41396-021-01123-5","volume":"16","author":"L Han","year":"2022","unstructured":"Han L, Zhao L, Zhou Y, Yang C, Xiong T, Lu L, et al. Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity. ISME J. 2022;16:983\u201396.","journal-title":"ISME J"},{"key":"4529_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/srep31148","volume":"6","author":"JM Panlilio","year":"2016","unstructured":"Panlilio JM, Marin S, Lobl MB, McDonald MD. Treatment with the selective serotonin reuptake inhibitor, fluoxetine, attenuates the fish hypoxia response. Sci Rep. 2016;6:31148.","journal-title":"Sci Rep"},{"key":"4529_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.152031","volume":"491","author":"Y Dou","year":"2024","unstructured":"Dou Y, Yang X, Du Y, Cui W, Luo Y, Wei J, et al. Early-relief effects of tetrahedral DNA nanostructures-assisted depression therapy via modulates hippocampal neurogenesis and neuroplasticity. Chem Eng J. 2024;491:152031.","journal-title":"Chem Eng J"},{"issue":"7","key":"4529_CR160","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.3390\/ijms26072916","volume":"26","author":"M Naoi","year":"2025","unstructured":"Naoi M, Wu Y, Maruyama W, Shamoto-Nagai M. Phytochemicals modulate biosynthesis and function of serotonin, dopamine, and norepinephrine for treatment of monoamine neurotransmission-related psychiatric diseases. Int J Mol Sci. 2025;26(7):2916.","journal-title":"Int J Mol Sci"},{"key":"4529_CR161","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202310608","volume":"20","author":"H Tan","year":"2024","unstructured":"Tan H, Cao K, Zhao Y, Zhong J, Deng D, Pan B, et al. Brain-targeted black phosphorus-based nanotherapeutic platform for enhanced hypericin delivery in depression. Small. 2024;20:e2310608.","journal-title":"Small"},{"key":"4529_CR162","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/jnen\/nlae066","volume":"83","author":"R Gober","year":"2024","unstructured":"Gober R, Dallmeier J, Davis D, Brzostowicki D, de Rivero Vaccari JP, Cyr B, et al. Increased inflammasome protein expression identified in microglia from postmortem brains with schizophrenia. J Neuropathol Exp Neurol. 2024;83:951\u201366.","journal-title":"J Neuropathol Exp Neurol"},{"key":"4529_CR163","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.genhosppsych.2023.09.011","volume":"87","author":"Y Matsumoto","year":"2024","unstructured":"Matsumoto Y, Ayani N, Oya N, Kitaoka R, Watanabe A, Yoshii H, et al. Frequency and predictors of perioperative psychiatric symptom worsening in patients with schizophrenia spectrum disorders. Gen Hosp Psychiatry. 2024;87:148\u201350.","journal-title":"Gen Hosp Psychiatry"},{"key":"4529_CR164","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4103\/0019-5545.166635","volume":"57","author":"CL Narayan","year":"2015","unstructured":"Narayan CL, Shikha D, Shekhar S. Schizophrenia in identical twins. Indian J Psychiatry. 2015;57:323\u20134.","journal-title":"Indian J Psychiatry"},{"issue":"Suppl A","key":"4529_CR165","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.clinthera.2005.07.016","volume":"27","author":"DR Weinberger","year":"2005","unstructured":"Weinberger DR. Genetic mechanisms of psychosis: in vivo and postmortem genomics. Clin Ther. 2005;27(Suppl A):S8\u201315.","journal-title":"Clin Ther"},{"key":"4529_CR166","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2174\/1568026616666160414124628","volume":"17","author":"NN Karpova","year":"2017","unstructured":"Karpova NN, Sales AJ, Joca SR. Epigenetic basis of neuronal and synaptic plasticity. Curr Top Med Chem. 2017;17:771\u201393.","journal-title":"Curr Top Med Chem"},{"key":"4529_CR167","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tins.2018.12.004","volume":"42","author":"RA McCutcheon","year":"2019","unstructured":"McCutcheon RA, Abi-Dargham A, Howes OD. Schizophrenia, dopamine and the striatum: from biology to symptoms. Trends Neurosci. 2019;42:205\u201320.","journal-title":"Trends Neurosci"},{"key":"4529_CR168","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1192\/j.eurpsy.2022.116","volume":"65","author":"G N\u00e9meth","year":"2022","unstructured":"N\u00e9meth G. From a pathophysiological concept to a new drug. Eur Psychiatry. 2022;65:S33\u2013S33.","journal-title":"Eur Psychiatry"},{"key":"4529_CR169","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/jnc.14290","volume":"145","author":"SN Isherwood","year":"2018","unstructured":"Isherwood SN, Robbins TW, Dalley JW, Pekcec A. Bidirectional variation in glutamate efflux in the medial prefrontal cortex induced by selective positive and negative allosteric mGluR5 modulators. J Neurochem. 2018;145:111\u201324.","journal-title":"J Neurochem"},{"key":"4529_CR170","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.672136","volume":"15","author":"W Yu","year":"2021","unstructured":"Yu W, Fang H, Zhang L, Hu M, He S, Li H, et al. Reversible changes in BDNF expression in MK-801-induced hippocampal astrocytes through NMDAR\/PI3K\/ERK signaling. Front Cell Neurosci. 2021;15:672136.","journal-title":"Front Cell Neurosci"},{"key":"4529_CR171","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03509-0","volume":"22","author":"D Szab\u00f3","year":"2025","unstructured":"Szab\u00f3 D, Otrokocsi L, Sperl\u00e1gh B. The role of maternal infections in neurodevelopmental psychiatric disorders: focus on the P2X7\/NLRP3\/IL-1\u03b2 signalling pathway. J Neuroinflammation. 2025;22:192.","journal-title":"J Neuroinflammation"},{"key":"4529_CR172","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.eurpsy.2017.01.146","volume":"41","author":"E Unternaehrer","year":"2017","unstructured":"Unternaehrer E, Greenlaw K, Hari Dass S, Chen LM, Bouvette-Turcot AA, Cost K, et al. Intergenerational transmission of well being\u2013genetic and epigenetic mechanisms. Eur Psychiatry. 2017;41:S29\u201330.","journal-title":"Eur Psychiatry"},{"key":"4529_CR173","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291725000078","volume":"55","author":"K Fang","year":"2025","unstructured":"Fang K, Wen B, Liu L, Han S, Zhang W. Disrupted intersubject variability architecture in structural and functional brain connectomes in major depressive disorder. Psychol Med. 2025;55:e56.","journal-title":"Psychol Med"},{"key":"4529_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114910","volume":"159","author":"H Huang","year":"2025","unstructured":"Huang H, Luo Z, Min J, Luo W, Zhou X, Wang C. Targeting neuroinflammation in schizophrenia: a comprehensive review of mechanisms and pharmacological interventions. Int Immunopharmacol. 2025;159:114910.","journal-title":"Int Immunopharmacol"},{"key":"4529_CR175","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1093\/cercor\/bhaa025","volume":"30","author":"A Mehr","year":"2020","unstructured":"Mehr A, Hick M, Ludewig S, M\u00fcller M, Herrmann U, von Engelhardt J, et al. Lack of APP and APLP2 in GABAergic forebrain neurons impairs synaptic plasticity and cognition. Cereb Cortex. 2020;30:4044\u201363.","journal-title":"Cereb Cortex"},{"key":"4529_CR176","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/pcn.12912","volume":"73","author":"Y Matsuda","year":"2019","unstructured":"Matsuda Y, Makinodan M, Morimoto T, Kishimoto T. Neural changes following cognitive remediation therapy for schizophrenia. Psychiatry Clin Neurosci. 2019;73:676\u201384.","journal-title":"Psychiatry Clin Neurosci"},{"key":"4529_CR177","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1038\/s41380-019-0492-3","volume":"24","author":"X Tian","year":"2019","unstructured":"Tian X, Richard A, El-Saadi MW, Bhandari A, Latimer B, Van Savage I, et al. Dosage sensitivity intolerance of VIPR2 microduplication is disease causative to manifest schizophrenia-like phenotypes in a novel BAC transgenic mouse model. Mol Psychiatry. 2019;24:1884\u2013901.","journal-title":"Mol Psychiatry"},{"key":"4529_CR178","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1021\/jacsau.4c00311","volume":"4","author":"K Sakamoto","year":"2024","unstructured":"Sakamoto K, Iwata S, Jin Z, Chen L, Miyaoka T, Yamada M, et al. Cyclic peptides KS-133 and KS-487 multifunctionalized nanoparticles enable efficient brain targeting for treating schizophrenia. JACS Au. 2024;4:2811\u20137.","journal-title":"JACS Au"},{"key":"4529_CR179","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1093\/schbul\/sby014.064","volume":"44","author":"S Bhattacharyya","year":"2018","unstructured":"Bhattacharyya S. 17. Cannabidiol as a treatment in different stages of psychosis- efficacy and mechanisms. Schizophr Bull. 2018;44:S27\u2013S27.","journal-title":"Schizophr Bull"},{"key":"4529_CR180","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2165\/00023210-200721070-00002","volume":"21","author":"JA Apud","year":"2007","unstructured":"Apud JA, Weinberger DR. Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors. CNS Drugs. 2007;21:535\u201357.","journal-title":"CNS Drugs"},{"key":"4529_CR181","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jconrel.2020.12.050","volume":"330","author":"MJ Majcher","year":"2021","unstructured":"Majcher MJ, Babar A, Lofts A, Leung A, Li X, Abu-Hijleh F, et al. In situ-gelling starch nanoparticle (SNP)\/O-carboxymethyl chitosan (CMCh) nanoparticle network hydrogels for the intranasal delivery of an antipsychotic peptide. J Control Release. 2021;330:738\u201352.","journal-title":"J Control Release"},{"issue":"6","key":"4529_CR182","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/pharmaceutics16060746","volume":"16","author":"H Omidian","year":"2024","unstructured":"Omidian H, Gill EJ, Dey Chowdhury S, Cubeddu LX. Chitosan nanoparticles for intranasal drug delivery. Pharmaceutics. 2024;16(6):746.","journal-title":"Pharmaceutics"},{"key":"4529_CR183","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.979682","volume":"13","author":"A Rajput","year":"2022","unstructured":"Rajput A, Pingale P, Dhapte-Pawar V. Nasal delivery of neurotherapeutics via nanocarriers: facets, aspects, and prospects. Front Pharmacol. 2022;13:979682.","journal-title":"Front Pharmacol"},{"key":"4529_CR184","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11920-018-0940-9","volume":"20","author":"S Suh","year":"2018","unstructured":"Suh S, Cho N, Zhang J. Sex differences in insomnia: from epidemiology and etiology to intervention. Curr Psychiatry Rep. 2018;20:69.","journal-title":"Curr Psychiatry Rep"},{"key":"4529_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2021.132633","volume":"430","author":"P Yu","year":"2022","unstructured":"Yu P, Zhang X, Cheng G, Guo H, Shi X, Zhang X, et al. Construction of a new multifunctional insomnia drug delivery system. Chem Eng J. 2022;430:132633.","journal-title":"Chem Eng J"},{"key":"4529_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.140831","volume":"303","author":"L Gao","year":"2025","unstructured":"Gao L, Gu L, Li W, Wang G, Zhao J, Chen W, et al. Construction of composite nanoparticles of \u03b2-cyclodextrin and corn starch encapsulating 5-hydroxytryptophan for sustained release and sleep improvement in vivo. Int J Biol Macromol. 2025;303:140831.","journal-title":"Int J Biol Macromol"},{"key":"4529_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106965","volume":"197","author":"L Chen","year":"2023","unstructured":"Chen L, Xiong XY, Yao TT, Gui LN, Luo F, Du Y, et al. Blood exosome sensing via neuronal insulin-like growth factor-1 regulates autism-related phenotypes. Pharmacol Res. 2023;197:106965.","journal-title":"Pharmacol Res"},{"key":"4529_CR188","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1021\/acsami.4c11663","volume":"17","author":"C Zhang","year":"2025","unstructured":"Zhang C, Yang L, Wang F, Liu M, Liu Z, Zou M, et al. Therapeutic efficacy of a synthetic brain-targeted H(2)S donor cross-linked nanomicelle in autism spectrum disorder rats through aerobic glycolysis. ACS Appl Mater Interfaces. 2025;17:157\u201373.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4529_CR189","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.7150\/thno.95614","volume":"14","author":"C Miao","year":"2024","unstructured":"Miao C, Shen Y, Lang Y, Li H, Gong Y, Liu Y, et al. Biomimetic nanoparticles with enhanced rapamycin delivery for autism spectrum disorder treatment via autophagy activation and oxidative stress modulation. Theranostics. 2024;14:4375\u201392.","journal-title":"Theranostics"},{"key":"4529_CR190","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202405655","volume":"36","author":"S Feng","year":"2024","unstructured":"Feng S, Gong Y, Xia L, Lang Y, Shen Y, Li H, et al. Calcium hexacyanoferrate (III) nanocatalyst enables redox homeostasis for autism spectrum disorder treatment. Adv Mater. 2024;36:e2405655.","journal-title":"Adv Mater"},{"key":"4529_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103671","volume":"84","author":"Y Gong","year":"2025","unstructured":"Gong Y, Yu L, Xia L, Jin J, Lang Y, Feng S, et al. Broad-spectrum antioxidant and neuroprotective Prussian blue nanocatalyst for therapeutic intervention in autism spectrum disorder. Redox Biol. 2025;84:103671.","journal-title":"Redox Biol"},{"key":"4529_CR192","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.nano.2015.06.006","volume":"11","author":"J Ma","year":"2015","unstructured":"Ma J, Porter AL, Aminabhavi TM, Zhu D. Nano-enabled drug delivery systems for brain cancer and Alzheimer\u2019s disease: research patterns and opportunities. Nanomedicine. 2015;11:1763\u201371.","journal-title":"Nanomedicine"},{"key":"4529_CR193","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbi.2023.11.004","volume":"115","author":"I Boyton","year":"2024","unstructured":"Boyton I, Valenzuela SM, Collins-Praino LE, Care A. Neuronanomedicine for Alzheimer\u2019s and Parkinson\u2019s disease: current progress and a guide to improve clinical translation. Brain Behav Immun. 2024;115:631\u201351.","journal-title":"Brain Behav Immun"},{"key":"4529_CR194","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70213","volume":"6","author":"Y Qiu","year":"2025","unstructured":"Qiu Y, Huang S, Peng L, Yang L, Zhang G, Liu T, et al. The nasal-brain drug delivery route: mechanisms and applications to central nervous system diseases. MedComm (2020). 2025;6:e70213.","journal-title":"MedComm (2020)"},{"key":"4529_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102291","volume":"97","author":"AK Roghani","year":"2024","unstructured":"Roghani AK, Garcia RI, Roghani A, Reddy A, Khemka S, Reddy RP, et al. Treating Alzheimer\u2019s disease using nanoparticle-mediated drug delivery strategies\/systems. Ageing Res Rev. 2024;97:102291.","journal-title":"Ageing Res Rev"},{"key":"4529_CR196","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2174\/1389450120666191118123151","volume":"21","author":"G Altinoglu","year":"2020","unstructured":"Altinoglu G, Adali T. Alzheimer\u2019s disease targeted nano-based drug delivery systems. Curr Drug Targets. 2020;21:628\u201346.","journal-title":"Curr Drug Targets"},{"key":"4529_CR197","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1898","volume":"15","author":"S Hernando","year":"2023","unstructured":"Hernando S, Santos-Vizca\u00edno E, Igartua M, Hernandez RM. Targeting the central nervous system: from synthetic nanoparticles to extracellular vesicles-focus on Alzheimer\u2019s and Parkinson\u2019s disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15:e1898.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"4529_CR198","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1463976","volume":"11","author":"A Kisku","year":"2024","unstructured":"Kisku A, Nishad A, Agrawal S, Paliwal R, Datusalia AK, Gupta G, et al. Recent developments in intranasal drug delivery of nanomedicines for the treatment of neuropsychiatric disorders. Front Med (Lausanne). 2024;11:1463976.","journal-title":"Front Med (Lausanne)"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04529-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04529-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04529-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:16:07Z","timestamp":1782209767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04529-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":198,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4529"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04529-5","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research registration unique identifying number (UIN)"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"587"}}